Live Breaking News & Updates on Globe newswire inmune bio inc

Stay updated with breaking news from Globe newswire inmune bio inc. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.

INmune Bio, Inc. Receives Health Canada "No Objection

BOCA RATON, FL., Nov. 14, 2022 (GLOBE NEWSWIRE) INmune Bio, Inc. (NASDAQ: INMB) (the “Company”), a clinical-stage immunology company focused on. ....

Australia , Canada , Inmune-bio , Globe-newswire-inmune-bio-inc , While-the-company , Health-canada , Companya-no-objection-letter , Nasdaq , Nasdaq-inmb , Inmune-bio , Nc ,

INmune Bio, Inc. Announces Third Quarter 2022 Results and Provides Business Update

INmune Bio, Inc. Announces Third Quarter 2022 Results and Provides Business Update
streetinsider.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from streetinsider.com Daily Mail and Mail on Sunday newspapers.

Australia , United-states , United-kingdom , American , Financialresultsforthe-quarterended , David-moss , Inmune-biocontact , Inmune-bio , Inmunebio-inc , Globe-newswire-inmune-bio-inc , Inmune-bio-inc , Company-current-reports-on-form

INmune Bio, Inc. to Provide Additional Manufacturing Information to FDA as Part of IND Application for XPro1595™ in Alzheimer's Disease

INmune Bio, Inc. to Provide Additional Manufacturing Information to FDA as Part of IND Application for XPro1595™ in Alzheimer's Disease
streetinsider.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from streetinsider.com Daily Mail and Mail on Sunday newspapers.

Australia , David-moss , Inmune-biocontact , Inmune-bio , Globe-newswire-inmune-bio-inc , Inmune-bio-inc , Company-investigational-new-drug , Company-current-reports-on-form , Drug-administration , Company-quarterly-reports-on-form , Nasdaq , Company-annual-report-on-form

INmune Bio, Inc. to Provide Additional Manufacturing Information to FDA as Part of IND Application for XPro1595™ in Alzheimer's Disease

INmune Bio, Inc. to Provide Additional Manufacturing Information to FDA as Part of IND Application for XPro1595™ in Alzheimer's Disease
streetinsider.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from streetinsider.com Daily Mail and Mail on Sunday newspapers.

Australia , David-moss , Inmune-biocontact , Inmune-bio , Jason-nelson , Globe-newswire-inmune-bio-inc , Inmune-bio-inc , Company-investigational-new-drug , Company-current-reports-on-form , Drug-administration , Company-quarterly-reports-on-form , Nasdaq

INmune Bio : Announces First Patient Dosed in Phase 2 XPro1595 Trial for Treatment of Neuroinflammation as a Cause of Alzheimer's disease - Form 8-K

INmune Bio Announces First Patient Dosed in Phase 2 XPro1595 Trial for Treatment of Neuroinflammation as a Cause of Alzheimer s disease

INmune Bio Plans to Enroll 201 Patients. | April 13, 2022 ....

Florida , United-states , Australia , Canada , Boca-raton , David-moss , Inmune-bio , Jason-nelson , Inmunebio-inc , Globe-newswire-inmune-bio-inc , Inmune-bio-inc , Company-current-reports-on-form